Stockscreener 앱 받기
222.82
0.66%
-1.49
시간 외 거래:
222.82
전일 마감가:
$224.31
열려 있는:
$224
하루 거래량:
5.02M
Relative Volume:
0.85
시가총액:
$393.81B
수익:
$59.64B
순이익/손실:
$2.36B
주가수익비율:
168.13
EPS:
1.3253
순현금흐름:
$19.68B
1주 성능:
-0.52%
1개월 성능:
-4.72%
6개월 성능:
+20.13%
1년 성능:
+28.78%
1일 변동 폭
$222.79
$226.26
1주일 범위
$221.10
$228.30
52주 변동 폭
$164.39
$244.81
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
ABBV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
222.82 | 396.44B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
1,056.88 | 932.42B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
208.31 | 506.75B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
135.27 | 259.09B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.69 | 246.17B | 63.90B | 19.05B | 13.05B | 7.5596 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
Is AbbVie a Millionaire Maker? - AOL.com
How cyclical is AbbVie Inc. stock compared to rivals2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Улправда
White House Readies Drug Price Deals With AbbVie, Novartis, Roche - Benzinga
AbbVie Inc. (ABBV) Starts Building $70 Million Expansion of Its AbbVie Bioresearch Centre in Worcester, Massachusetts - MSN
34,329 Shares in AbbVie Inc. $ABBV Purchased by Montecito Bank & Trust - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Cuts Stake in AbbVie Inc. $ABBV - MarketBeat
Union Bancaire Privee UBP SA Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
IPO Launch: Is AbbVie Inc. stock a top pick in earnings seasonJuly 2025 EndofMonth & Daily Stock Trend Reports - Улправда
AbbVie Inc. $ABBV Shares Sold by Carolina Wealth Advisors LLC - MarketBeat
University of Chicago Extends Collaboration with AbbVie to Advance Clinical Research and Patient Outcomes in Oncology | Newswise - Newswise
Analysts split on AbbVie Inc. (ABBV) as BofA cuts target and HSBC turns bullish - MSN
AbbVie, several other pharma companies near MFN deal with Trump, sources say - Reuters
Analysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns Bullish - Insider Monkey
Looking At AbbVie's Recent Unusual Options Activity - Benzinga
Final trades: AbbVie Inc, Microsoft, Netflix and Twilio Inc - MSN
Want Decades of Passive Income? Buy This ETF and Hold It Forever. - The Motley Fool
Final Trades: Abbvie Inc, Microsoft, Netflix and Twilio Inc - CNBC
Evercore ISI Adjusts AbbVie Price Target to $233 From $222, Maintains Outperform Rating - marketscreener.com
TruWealth Advisors LLC Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - Yahoo Finance
Sanders Morris Harris LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Gradient Investments LLC Reduces Stake in AbbVie Inc. $ABBV - MarketBeat
Aaron Wealth Advisors LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Has AbbVie’s 24.6% 2025 Rally Left Further Upside After Strong DCF Signals? - Yahoo Finance
AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus - ts2.tech
AbbVie (NYSE:ABBV) Stock Price Down 1.6%Here's What Happened - MarketBeat
AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
How AbbVie's pipeline is lining up key product launches - MSN
How AbbVie's Pipeline Is Lining Up Key Product Launches - The Globe and Mail
AbbVie price target lowered to $233 from $248 at BofA - Yahoo Finance
St. Louis Financial Planners Asset Management LLC Takes $3.39 Million Position in AbbVie Inc. $ABBV - MarketBeat
32,205 Shares in AbbVie Inc. $ABBV Purchased by Shorepoint Capital Partners LLC - MarketBeat
Park National Corp OH Decreases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Corient Private Wealth LLC Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by GAMMA Investing LLC - MarketBeat
Is AbbVie stock too cheap to ignore at today's price? - MSN
AbbVie (NYSE:ABBV) Stock Price Up 1.9%Time to Buy? - MarketBeat
AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance
AbbVie’s Growth Story Faces A Pipeline Pause - Finimize
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie (ABBV) Stock News and Forecasts Today: BofA Cuts Price Target to $233 as Wall Street Debates 2026 Pipeline Catalysts - ts2.tech
AbbVie’s (ABBV) Options Flow Implies That the Smart Money Could Be Up to Something - Barchart.com
The Power of Partnership: An Innovative Approach to Improve Maternal Health - AbbVie
Addressing Systemic Barriers - AbbVie
AbbVie's Upside Potential Limited in Pipeline-Light 2026, BofA Securities Says - marketscreener.com
Valeo Financial Advisors LLC Sells 29,989 Shares of AbbVie Inc. $ABBV - MarketBeat
Texas Permanent School Fund Corp Sells 46,907 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Hold Rating: Balancing Growth Opportunities with Valuation and Pipeline Challenges - TipRanks
Orion Porfolio Solutions LLC Purchases 16,520 Shares of AbbVie Inc. $ABBV - MarketBeat
Stonebridge Wealth Management LLC Purchases New Stake in AbbVie Inc. $ABBV - MarketBeat
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
0.18%
자본화:
|
볼륨(24시간):